Shukla Janki, Schmidt Christian, Larson David, Murthy Avinash, Chambers Jenny, Garberich Ross, Smith Lincoln, Yildiz Mehmet, Quesada Odayme, Mattingly Georgia, Garcia Santiago, Sharkey Scott, Henry Timothy D
University of Cincinnati, College of Medicine, Cincinnati, OH.
Minneapolis Heart Institute and Foundation, Minneapolis, MN.
Am Heart J. 2025 Dec;290:230-237. doi: 10.1016/j.ahj.2025.06.013. Epub 2025 Jun 27.
Nonagenarians with ST-elevation myocardial infarction (STEMI) represent a unique and growing population and are underrepresented in clinical trials due to arbitrary exclusion criteria. Therefore, a thorough examination of STEMI in this age population may better inform management decisions.
This is a cohort study examining the Midwest STEMI Consortium database from March 2003 through October 2020. All patients with STEMI, presenting within 24 hours of symptom onset, were enrolled -including those with advanced age, cardiogenic shock, or out-of-hospital cardiac arrest. Data are described across age groups: <70, 70-79, 80-89, and ≥90 years. Main outcome measures were discharge disposition; mortality in-hospital, 30-days, and 1-year.
Among 15,039 consecutive STEMI patients, 303 (2%) were ≥90 years, of whom 194 (64%) were females. Among nonagenarians, mortality was 17% in the hospital, 20% at 30-day, and 33% at 1-year; and those living in a skilled nursing facility (SNF) before presentation had significantly higher in-hospital mortality (36%) versus those living at home or in an assisted living facility (ALF) (14% and 15% respectively). The mortality at 1 year was 13% for patients discharged to home, 20% for those discharged with home health care or ALF, and 43% for those discharged to SNF (P < .001).
In this large multicenter prospective STEMI database, nonagenarians living in SNF before presentation had more than 2-fold higher in-hospital mortality than those living at home. Furthermore, patients discharged to SNF had a 3-fold higher 1-year mortality than those discharged to home. In this older STEMI population, living status before the presentation and at hospital discharge carries important prognostic information.
患有ST段抬高型心肌梗死(STEMI)的九旬老人是一个独特且不断增长的群体,由于任意的排除标准,他们在临床试验中的代表性不足。因此,对这个年龄段人群的STEMI进行全面检查可能会更好地为管理决策提供信息。
这是一项队列研究,研究了2003年3月至2020年10月的中西部STEMI联盟数据库。纳入所有在症状发作24小时内就诊的STEMI患者,包括高龄、心源性休克或院外心脏骤停的患者。数据按年龄组进行描述:<70岁、70 - 79岁、80 - 89岁和≥90岁。主要结局指标为出院处置情况;住院死亡率、30天死亡率和1年死亡率。
在15039例连续的STEMI患者中,303例(2%)年龄≥90岁,其中194例(64%)为女性。在九旬老人中,住院死亡率为17%,30天死亡率为20%,1年死亡率为33%;就诊前住在专业护理机构(SNF)的患者住院死亡率(36%)显著高于住在家里或辅助生活设施(ALF)的患者(分别为14%和15%)。出院回家的患者一年死亡率为13%,出院接受家庭医疗或入住ALF的患者为20%,出院至SNF的患者为43%(P < 0.001)。
在这个大型多中心前瞻性STEMI数据库中,就诊前住在SNF的九旬老人住院死亡率比住在家里的老人高出两倍多。此外,出院至SNF的患者1年死亡率比出院回家的患者高出三倍。在这个老年STEMI人群中,就诊前和出院时的生活状况具有重要的预后信息。